FDA Drug Application (019129) for MAXZIDE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number019129
Product Number001
FormTABLET;ORAL
Dosage50MG;75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMAXZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TRIAMTERENE5


Back to FDA Applications sponsored by MYLAN PHARMS INC